Eli Lilly boss calls out Australia on Mounjaro and Trump over kids vaccines
Mounjaro is still not available on the PBS as Eli Lilly negotiates price points but the company's CEO says the door remains open.
Eli Lilly's CEO David Ricks criticised Australia's approach to the pricing of Mounjaro, a drug used for weight loss and type 2 diabetes treatment. Ricks remains open to bringing the drug into Australia's Pharmaceutical Benefits Scheme (PBS) but emphasised that a fair price is essential. The company had previously rejected a deal due to unrealistic price conditions.
Ricks warned that lowering the cost for Australia could have global consequences. Meanwhile, US President Donald Trump proposed a reduced vaccination schedule for children, dropping six diseases recommended by the CDC. Ricks expressed hope that the US scientific community would question the proposed changes, particularly the link between vaccines and autism, stressing the need for evidence before making any alterations to the schedule.
Written by urgent.news from ABC News AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
